Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörg Schrader

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Journal of Hepatology|August 21, 2013
The role of MDSCs in hepatocellular carcinoma--in vivo veritas?Jörg Schrader
Oncoimmunology|June 22, 2012
Chronic liver inflammation dominated by interferon-γ can prevent hepatocarcinogenesisJörg Schrader, Johannes Herkel
Journal of Hepatology|December 28, 2010
The inflammatory microenvironment of HCC - the plot becomes complexJörg Schrader, John P Iredale
Cancers|June 10, 2022
Updates on Diagnostic and Therapeutic Management of Gastrointestinal and Pancreatic NETSebastian Krug, Jörg Schrader, Anja Rinke
Hepatology (Baltimore, Md.)|February 27, 2009
Senescence of activated stellate cells: not just early retirementJörg Schrader, Jonathan Fallowfield, John P Iredale
Zentralblatt Fur Chirurgie|June 15, 2022
[Endoscopic Resection for GEP-NET]Hanno Ehlken, Fadi Younis, Stefan Wolter, et al.
Zeitschrift Fur Gastroenterologie|January 28, 2021
Gastric NET Subtypes: Do We Need An Additional One?Guntram Lock, Michael Oelckers, Till Sebastian Clauditz, et al.
Biology|April 3, 2021
Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine NeoplasmsLeonidas Apostolidis, Jörg Schrader, Henning Jann, et al.
Cancers|January 8, 2023
The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different PrognosesHendrik Ungefroren, Björn Konukiewitz, Ulrich F Wellner, et al.
Immunology|April 19, 2017
Activation of the Akt-CREB signalling axis by a proline-rich heptapeptide confers resistance to stress-induced cell death and inflammationJohannes Herkel, Jörg Schrader, Neta Erez, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|August 21, 2013
The role of MDSCs in hepatocellular carcinoma--in vivo veritas?Jörg Schrader
Oncoimmunology|June 22, 2012
Chronic liver inflammation dominated by interferon-γ can prevent hepatocarcinogenesisJörg Schrader, Johannes Herkel
Journal of Hepatology|December 28, 2010
The inflammatory microenvironment of HCC - the plot becomes complexJörg Schrader, John P Iredale
Cancers|June 10, 2022
Updates on Diagnostic and Therapeutic Management of Gastrointestinal and Pancreatic NETSebastian Krug, Jörg Schrader, Anja Rinke
Hepatology (Baltimore, Md.)|February 27, 2009
Senescence of activated stellate cells: not just early retirementJörg Schrader, Jonathan Fallowfield, John P Iredale
Zentralblatt Fur Chirurgie|June 15, 2022
[Endoscopic Resection for GEP-NET]Hanno Ehlken, Fadi Younis, Stefan Wolter, et al.
Zeitschrift Fur Gastroenterologie|January 28, 2021
Gastric NET Subtypes: Do We Need An Additional One?Guntram Lock, Michael Oelckers, Till Sebastian Clauditz, et al.
Biology|April 3, 2021
Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine NeoplasmsLeonidas Apostolidis, Jörg Schrader, Henning Jann, et al.
Cancers|January 8, 2023
The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different PrognosesHendrik Ungefroren, Björn Konukiewitz, Ulrich F Wellner, et al.
Immunology|April 19, 2017
Activation of the Akt-CREB signalling axis by a proline-rich heptapeptide confers resistance to stress-induced cell death and inflammationJohannes Herkel, Jörg Schrader, Neta Erez, et al.
Pageof 7